Aptorum Group Limited
Get $10 bonus on your first $100 deposit for APM
Get $10 bonus on your first $100 deposit for APM
Aptorum Group Limited (APM) Stock Competitors & Peer Comparison
See (APM) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| APM | $0.89 | -1.39% | 5.6M | -4.68 | -$0.19 | N/A |
| VRTX | $436.59 | -0.59% | 111.1B | 28.48 | $15.33 | N/A |
| REGN | $747.36 | -0.27% | 77.7B | 17.91 | $41.73 | +0.24% |
| VRNA | $106.91 | +0.11% | 72.7B | -102.80 | -$1.04 | N/A |
| ARGX | $805.38 | -3.48% | 49.9B | 41.10 | $19.61 | N/A |
| SGEN | $228.74 | -0.07% | 43.2B | -57.19 | -$4.00 | N/A |
| ALNY | $308.43 | -0.81% | 40.9B | 131.78 | $2.34 | N/A |
| INSM | $140.98 | -1.29% | 30.4B | -21.93 | -$6.43 | N/A |
| RVMD | $148.90 | +1.83% | 29.5B | -24.98 | -$5.96 | N/A |
| BNTX | $111.60 | +6.09% | 28B | -20.11 | -$5.55 | N/A |
Stock Comparison
APM vs VRTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, VRTX has a market cap of 111.1B. Regarding current trading prices, APM is priced at $0.89, while VRTX trades at $436.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas VRTX's P/E ratio is 28.48. In terms of profitability, APM's ROE is -0.06%, compared to VRTX's ROE of +0.23%. Regarding short-term risk, APM is more volatile compared to VRTX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check VRTX's competition here
APM vs REGN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, REGN has a market cap of 77.7B. Regarding current trading prices, APM is priced at $0.89, while REGN trades at $747.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas REGN's P/E ratio is 17.91. In terms of profitability, APM's ROE is -0.06%, compared to REGN's ROE of +0.15%. Regarding short-term risk, APM is more volatile compared to REGN. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check REGN's competition here
APM vs VRNA Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, VRNA has a market cap of 72.7B. Regarding current trading prices, APM is priced at $0.89, while VRNA trades at $106.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas VRNA's P/E ratio is -102.80. In terms of profitability, APM's ROE is -0.06%, compared to VRNA's ROE of -0.13%. Regarding short-term risk, APM is more volatile compared to VRNA. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check VRNA's competition here
APM vs ARGX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ARGX has a market cap of 49.9B. Regarding current trading prices, APM is priced at $0.89, while ARGX trades at $805.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ARGX's P/E ratio is 41.10. In terms of profitability, APM's ROE is -0.06%, compared to ARGX's ROE of +0.34%. Regarding short-term risk, APM is more volatile compared to ARGX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ARGX's competition here
APM vs SGEN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, SGEN has a market cap of 43.2B. Regarding current trading prices, APM is priced at $0.89, while SGEN trades at $228.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas SGEN's P/E ratio is -57.19. In terms of profitability, APM's ROE is -0.06%, compared to SGEN's ROE of -0.21%. Regarding short-term risk, APM is more volatile compared to SGEN. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check SGEN's competition here
APM vs ALNY Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ALNY has a market cap of 40.9B. Regarding current trading prices, APM is priced at $0.89, while ALNY trades at $308.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ALNY's P/E ratio is 131.78. In terms of profitability, APM's ROE is -0.06%, compared to ALNY's ROE of +0.90%. Regarding short-term risk, APM is more volatile compared to ALNY. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ALNY's competition here
APM vs INSM Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, INSM has a market cap of 30.4B. Regarding current trading prices, APM is priced at $0.89, while INSM trades at $140.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas INSM's P/E ratio is -21.93. In terms of profitability, APM's ROE is -0.06%, compared to INSM's ROE of -1.68%. Regarding short-term risk, APM is more volatile compared to INSM. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check INSM's competition here
APM vs RVMD Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, RVMD has a market cap of 29.5B. Regarding current trading prices, APM is priced at $0.89, while RVMD trades at $148.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas RVMD's P/E ratio is -24.98. In terms of profitability, APM's ROE is -0.06%, compared to RVMD's ROE of -0.63%. Regarding short-term risk, APM is more volatile compared to RVMD. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check RVMD's competition here
APM vs BNTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, BNTX has a market cap of 28B. Regarding current trading prices, APM is priced at $0.89, while BNTX trades at $111.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas BNTX's P/E ratio is -20.11. In terms of profitability, APM's ROE is -0.06%, compared to BNTX's ROE of -0.06%. Regarding short-term risk, APM is less volatile compared to BNTX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check BNTX's competition here
APM vs UTHR Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, UTHR has a market cap of 25.1B. Regarding current trading prices, APM is priced at $0.89, while UTHR trades at $573.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas UTHR's P/E ratio is 20.57. In terms of profitability, APM's ROE is -0.06%, compared to UTHR's ROE of +0.19%. Regarding short-term risk, APM is more volatile compared to UTHR. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check UTHR's competition here
APM vs MRNA Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, MRNA has a market cap of 21.4B. Regarding current trading prices, APM is priced at $0.89, while MRNA trades at $54.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas MRNA's P/E ratio is -7.47. In terms of profitability, APM's ROE is -0.06%, compared to MRNA's ROE of -0.30%. Regarding short-term risk, APM is less volatile compared to MRNA. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check MRNA's competition here
APM vs RPRX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, RPRX has a market cap of 21.2B. Regarding current trading prices, APM is priced at $0.89, while RPRX trades at $49.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas RPRX's P/E ratio is 27.80. In terms of profitability, APM's ROE is -0.06%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, APM is more volatile compared to RPRX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check RPRX's competition here
APM vs ROIV Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ROIV has a market cap of 21B. Regarding current trading prices, APM is priced at $0.89, while ROIV trades at $29.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ROIV's P/E ratio is -25.03. In terms of profitability, APM's ROE is -0.06%, compared to ROIV's ROE of -0.18%. Regarding short-term risk, APM is more volatile compared to ROIV. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ROIV's competition here
APM vs SMMT Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, SMMT has a market cap of 20.5B. Regarding current trading prices, APM is priced at $0.89, while SMMT trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas SMMT's P/E ratio is -18.32. In terms of profitability, APM's ROE is -0.06%, compared to SMMT's ROE of -2.97%. Regarding short-term risk, APM is less volatile compared to SMMT. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check SMMT's competition here
APM vs BGNE Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, BGNE has a market cap of 20.2B. Regarding current trading prices, APM is priced at $0.89, while BGNE trades at $184.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas BGNE's P/E ratio is -22.55. In terms of profitability, APM's ROE is -0.06%, compared to BGNE's ROE of +0.07%. Regarding short-term risk, APM is more volatile compared to BGNE. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check BGNE's competition here
APM vs INCY Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, INCY has a market cap of 19.1B. Regarding current trading prices, APM is priced at $0.89, while INCY trades at $96.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas INCY's P/E ratio is 15.01. In terms of profitability, APM's ROE is -0.06%, compared to INCY's ROE of +0.29%. Regarding short-term risk, APM is more volatile compared to INCY. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check INCY's competition here
APM vs DNA-WT Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, DNA-WT has a market cap of 18.7B. Regarding current trading prices, APM is priced at $0.89, while DNA-WT trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas DNA-WT's P/E ratio is N/A. In terms of profitability, APM's ROE is -0.06%, compared to DNA-WT's ROE of -0.54%. Regarding short-term risk, APM is less volatile compared to DNA-WT. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check DNA-WT's competition here
APM vs GMAB Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, GMAB has a market cap of 16.7B. Regarding current trading prices, APM is priced at $0.89, while GMAB trades at $27.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas GMAB's P/E ratio is 17.57. In terms of profitability, APM's ROE is -0.06%, compared to GMAB's ROE of +0.14%. Regarding short-term risk, APM is more volatile compared to GMAB. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check GMAB's competition here
APM vs BBIO Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, BBIO has a market cap of 14.8B. Regarding current trading prices, APM is priced at $0.89, while BBIO trades at $76.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas BBIO's P/E ratio is -20.15. In terms of profitability, APM's ROE is -0.06%, compared to BBIO's ROE of +0.39%. Regarding short-term risk, APM is more volatile compared to BBIO. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check BBIO's competition here
APM vs ASND Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ASND has a market cap of 14.8B. Regarding current trading prices, APM is priced at $0.89, while ASND trades at $240.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ASND's P/E ratio is -54.00. In terms of profitability, APM's ROE is -0.06%, compared to ASND's ROE of +1.28%. Regarding short-term risk, APM is less volatile compared to ASND. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check ASND's competition here
APM vs KRTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, KRTX has a market cap of 12.6B. Regarding current trading prices, APM is priced at $0.89, while KRTX trades at $329.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas KRTX's P/E ratio is -28.09. In terms of profitability, APM's ROE is -0.06%, compared to KRTX's ROE of -0.36%. Regarding short-term risk, APM is more volatile compared to KRTX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check KRTX's competition here
APM vs IONS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, IONS has a market cap of 12.4B. Regarding current trading prices, APM is priced at $0.89, while IONS trades at $74.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas IONS's P/E ratio is -31.44. In terms of profitability, APM's ROE is -0.06%, compared to IONS's ROE of -0.69%. Regarding short-term risk, APM is more volatile compared to IONS. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check IONS's competition here
APM vs JAZZ Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, JAZZ has a market cap of 12.2B. Regarding current trading prices, APM is priced at $0.89, while JAZZ trades at $199.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas JAZZ's P/E ratio is -34.06. In terms of profitability, APM's ROE is -0.06%, compared to JAZZ's ROE of -0.09%. Regarding short-term risk, APM is more volatile compared to JAZZ. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check JAZZ's competition here
APM vs MDGL Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, MDGL has a market cap of 12.1B. Regarding current trading prices, APM is priced at $0.89, while MDGL trades at $527.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas MDGL's P/E ratio is -41.03. In terms of profitability, APM's ROE is -0.06%, compared to MDGL's ROE of -0.44%. Regarding short-term risk, APM is more volatile compared to MDGL. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check MDGL's competition here
APM vs EXEL Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, EXEL has a market cap of 11.9B. Regarding current trading prices, APM is priced at $0.89, while EXEL trades at $45.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas EXEL's P/E ratio is 16.51. In terms of profitability, APM's ROE is -0.06%, compared to EXEL's ROE of +0.37%. Regarding short-term risk, APM is more volatile compared to EXEL. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check EXEL's competition here
APM vs RNAM Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, RNAM has a market cap of 11.3B. Regarding current trading prices, APM is priced at $0.89, while RNAM trades at $72.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas RNAM's P/E ratio is -17.39. In terms of profitability, APM's ROE is -0.06%, compared to RNAM's ROE of -0.45%. Regarding short-term risk, APM is more volatile compared to RNAM. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check RNAM's competition here
APM vs BMRN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, BMRN has a market cap of 10.5B. Regarding current trading prices, APM is priced at $0.89, while BMRN trades at $54.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas BMRN's P/E ratio is 30.34. In terms of profitability, APM's ROE is -0.06%, compared to BMRN's ROE of +0.06%. Regarding short-term risk, APM is more volatile compared to BMRN. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check BMRN's competition here
APM vs ARWR Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ARWR has a market cap of 9.9B. Regarding current trading prices, APM is priced at $0.89, while ARWR trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ARWR's P/E ratio is 44.40. In terms of profitability, APM's ROE is -0.06%, compared to ARWR's ROE of +0.36%. Regarding short-term risk, APM is less volatile compared to ARWR. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check ARWR's competition here
APM vs RXDX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, RXDX has a market cap of 9.6B. Regarding current trading prices, APM is priced at $0.89, while RXDX trades at $199.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas RXDX's P/E ratio is -56.47. In terms of profitability, APM's ROE is -0.06%, compared to RXDX's ROE of -0.31%. Regarding short-term risk, APM is more volatile compared to RXDX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check RXDX's competition here
APM vs AXSM Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, AXSM has a market cap of 9.4B. Regarding current trading prices, APM is priced at $0.89, while AXSM trades at $182.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas AXSM's P/E ratio is -49.58. In terms of profitability, APM's ROE is -0.06%, compared to AXSM's ROE of -2.54%. Regarding short-term risk, APM is more volatile compared to AXSM. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check AXSM's competition here
APM vs TECH Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, TECH has a market cap of 9.3B. Regarding current trading prices, APM is priced at $0.89, while TECH trades at $59.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas TECH's P/E ratio is 110.50. In terms of profitability, APM's ROE is -0.06%, compared to TECH's ROE of +0.04%. Regarding short-term risk, APM is less volatile compared to TECH. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check TECH's competition here
APM vs IMGN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, IMGN has a market cap of 8.7B. Regarding current trading prices, APM is priced at $0.89, while IMGN trades at $31.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas IMGN's P/E ratio is -111.55. In terms of profitability, APM's ROE is -0.06%, compared to IMGN's ROE of -0.93%. Regarding short-term risk, APM is more volatile compared to IMGN. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check IMGN's competition here
APM vs PCVX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, PCVX has a market cap of 8.7B. Regarding current trading prices, APM is priced at $0.89, while PCVX trades at $60.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas PCVX's P/E ratio is -10.75. In terms of profitability, APM's ROE is -0.06%, compared to PCVX's ROE of -0.26%. Regarding short-term risk, APM is more volatile compared to PCVX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check PCVX's competition here
APM vs BPMC Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, BPMC has a market cap of 8.4B. Regarding current trading prices, APM is priced at $0.89, while BPMC trades at $129.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas BPMC's P/E ratio is -51.58. In terms of profitability, APM's ROE is -0.06%, compared to BPMC's ROE of -0.15%. Regarding short-term risk, APM is more volatile compared to BPMC. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check BPMC's competition here
APM vs IBRX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, IBRX has a market cap of 8.3B. Regarding current trading prices, APM is priced at $0.89, while IBRX trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas IBRX's P/E ratio is -21.32. In terms of profitability, APM's ROE is -0.06%, compared to IBRX's ROE of +0.64%. Regarding short-term risk, APM is less volatile compared to IBRX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check IBRX's competition here
APM vs CERE Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CERE has a market cap of 8.2B. Regarding current trading prices, APM is priced at $0.89, while CERE trades at $44.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CERE's P/E ratio is -16.47. In terms of profitability, APM's ROE is -0.06%, compared to CERE's ROE of -0.72%. Regarding short-term risk, APM is more volatile compared to CERE. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check CERE's competition here
APM vs HALO Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, HALO has a market cap of 8.1B. Regarding current trading prices, APM is priced at $0.89, while HALO trades at $68.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas HALO's P/E ratio is 26.72. In terms of profitability, APM's ROE is -0.06%, compared to HALO's ROE of +0.93%. Regarding short-term risk, APM is more volatile compared to HALO. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check HALO's competition here
APM vs CYTK Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CYTK has a market cap of 8.1B. Regarding current trading prices, APM is priced at $0.89, while CYTK trades at $65.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CYTK's P/E ratio is -10.06. In terms of profitability, APM's ROE is -0.06%, compared to CYTK's ROE of +1.73%. Regarding short-term risk, APM is more volatile compared to CYTK. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check CYTK's competition here
APM vs KRYS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, KRYS has a market cap of 8B. Regarding current trading prices, APM is priced at $0.89, while KRYS trades at $272.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas KRYS's P/E ratio is 39.92. In terms of profitability, APM's ROE is -0.06%, compared to KRYS's ROE of +0.19%. Regarding short-term risk, APM is more volatile compared to KRYS. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check KRYS's competition here
APM vs NUVL Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, NUVL has a market cap of 7.8B. Regarding current trading prices, APM is priced at $0.89, while NUVL trades at $107.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas NUVL's P/E ratio is -18.31. In terms of profitability, APM's ROE is -0.06%, compared to NUVL's ROE of -0.42%. Regarding short-term risk, APM is more volatile compared to NUVL. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check NUVL's competition here
APM vs MTSR Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, MTSR has a market cap of 7.4B. Regarding current trading prices, APM is priced at $0.89, while MTSR trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas MTSR's P/E ratio is -23.58. In terms of profitability, APM's ROE is -0.06%, compared to MTSR's ROE of -0.80%. Regarding short-term risk, APM is more volatile compared to MTSR. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check MTSR's competition here
APM vs ABVX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ABVX has a market cap of 7.3B. Regarding current trading prices, APM is priced at $0.89, while ABVX trades at $111.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ABVX's P/E ratio is -19.55. In terms of profitability, APM's ROE is -0.06%, compared to ABVX's ROE of -1.59%. Regarding short-term risk, APM is less volatile compared to ABVX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check ABVX's competition here
APM vs PRAX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, PRAX has a market cap of 7.2B. Regarding current trading prices, APM is priced at $0.89, while PRAX trades at $340.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas PRAX's P/E ratio is -25.28. In terms of profitability, APM's ROE is -0.06%, compared to PRAX's ROE of -0.59%. Regarding short-term risk, APM is more volatile compared to PRAX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check PRAX's competition here
APM vs KYMR Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, KYMR has a market cap of 7.2B. Regarding current trading prices, APM is priced at $0.89, while KYMR trades at $88.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas KYMR's P/E ratio is -23.87. In terms of profitability, APM's ROE is -0.06%, compared to KYMR's ROE of -0.29%. Regarding short-term risk, APM is more volatile compared to KYMR. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check KYMR's competition here
APM vs ERAS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ERAS has a market cap of 7B. Regarding current trading prices, APM is priced at $0.89, while ERAS trades at $22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ERAS's P/E ratio is -50.93. In terms of profitability, APM's ROE is -0.06%, compared to ERAS's ROE of -0.34%. Regarding short-term risk, APM is less volatile compared to ERAS. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check ERAS's competition here
APM vs MRUS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, MRUS has a market cap of 6.8B. Regarding current trading prices, APM is priced at $0.89, while MRUS trades at $90.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas MRUS's P/E ratio is -17.05. In terms of profitability, APM's ROE is -0.06%, compared to MRUS's ROE of -0.51%. Regarding short-term risk, APM is more volatile compared to MRUS. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check MRUS's competition here
APM vs PTGX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, PTGX has a market cap of 6.8B. Regarding current trading prices, APM is priced at $0.89, while PTGX trades at $105.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas PTGX's P/E ratio is -51.65. In terms of profitability, APM's ROE is -0.06%, compared to PTGX's ROE of -0.20%. Regarding short-term risk, APM is more volatile compared to PTGX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check PTGX's competition here
APM vs ACLX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ACLX has a market cap of 6.7B. Regarding current trading prices, APM is priced at $0.89, while ACLX trades at $114.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ACLX's P/E ratio is -28.25. In terms of profitability, APM's ROE is -0.06%, compared to ACLX's ROE of -0.55%. Regarding short-term risk, APM is more volatile compared to ACLX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ACLX's competition here
APM vs BLTE Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, BLTE has a market cap of 6.6B. Regarding current trading prices, APM is priced at $0.89, while BLTE trades at $165.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas BLTE's P/E ratio is -71.34. In terms of profitability, APM's ROE is -0.06%, compared to BLTE's ROE of -0.23%. Regarding short-term risk, APM is more volatile compared to BLTE. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check BLTE's competition here
APM vs RETA Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, RETA has a market cap of 6.6B. Regarding current trading prices, APM is priced at $0.89, while RETA trades at $172.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas RETA's P/E ratio is -66.29. In terms of profitability, APM's ROE is -0.06%, compared to RETA's ROE of +0.47%. Regarding short-term risk, APM is more volatile compared to RETA. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check RETA's competition here
APM vs CELC Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CELC has a market cap of 6.1B. Regarding current trading prices, APM is priced at $0.89, while CELC trades at $126.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CELC's P/E ratio is -33.21. In terms of profitability, APM's ROE is -0.06%, compared to CELC's ROE of -2.03%. Regarding short-term risk, APM is less volatile compared to CELC. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check CELC's competition here
APM vs CGON Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CGON has a market cap of 6.1B. Regarding current trading prices, APM is priced at $0.89, while CGON trades at $71.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CGON's P/E ratio is -34.54. In terms of profitability, APM's ROE is -0.06%, compared to CGON's ROE of -0.23%. Regarding short-term risk, APM is less volatile compared to CGON. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check CGON's competition here
APM vs COGT Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, COGT has a market cap of 6B. Regarding current trading prices, APM is priced at $0.89, while COGT trades at $36.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas COGT's P/E ratio is -17.00. In terms of profitability, APM's ROE is -0.06%, compared to COGT's ROE of -1.00%. Regarding short-term risk, APM is more volatile compared to COGT. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check COGT's competition here
APM vs CNTA Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CNTA has a market cap of 5.9B. Regarding current trading prices, APM is priced at $0.89, while CNTA trades at $39.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CNTA's P/E ratio is -27.05. In terms of profitability, APM's ROE is -0.06%, compared to CNTA's ROE of -0.51%. Regarding short-term risk, APM is more volatile compared to CNTA. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check CNTA's competition here
APM vs CAI Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CAI has a market cap of 5.9B. Regarding current trading prices, APM is priced at $0.89, while CAI trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CAI's P/E ratio is -6.47. In terms of profitability, APM's ROE is -0.06%, compared to CAI's ROE of +0.25%. Regarding short-term risk, APM is less volatile compared to CAI. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check CAI's competition here
APM vs PTCT Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, PTCT has a market cap of 5.8B. Regarding current trading prices, APM is priced at $0.89, while PTCT trades at $70.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas PTCT's P/E ratio is 8.23. In terms of profitability, APM's ROE is -0.06%, compared to PTCT's ROE of -3.62%. Regarding short-term risk, APM is more volatile compared to PTCT. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check PTCT's competition here
APM vs RYTM Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, RYTM has a market cap of 5.8B. Regarding current trading prices, APM is priced at $0.89, while RYTM trades at $84.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas RYTM's P/E ratio is -27.31. In terms of profitability, APM's ROE is -0.06%, compared to RYTM's ROE of -1.79%. Regarding short-term risk, APM is less volatile compared to RYTM. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check RYTM's competition here
APM vs TGTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, TGTX has a market cap of 5.8B. Regarding current trading prices, APM is priced at $0.89, while TGTX trades at $36.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas TGTX's P/E ratio is 13.10. In terms of profitability, APM's ROE is -0.06%, compared to TGTX's ROE of +1.01%. Regarding short-term risk, APM is more volatile compared to TGTX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check TGTX's competition here
APM vs IMVT Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, IMVT has a market cap of 5.8B. Regarding current trading prices, APM is priced at $0.89, while IMVT trades at $28.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas IMVT's P/E ratio is -10.60. In terms of profitability, APM's ROE is -0.06%, compared to IMVT's ROE of -0.66%. Regarding short-term risk, APM is more volatile compared to IMVT. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check IMVT's competition here
APM vs CDTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CDTX has a market cap of 5.6B. Regarding current trading prices, APM is priced at $0.89, while CDTX trades at $221.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CDTX's P/E ratio is -19.77. In terms of profitability, APM's ROE is -0.06%, compared to CDTX's ROE of -0.60%. Regarding short-term risk, APM is more volatile compared to CDTX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check CDTX's competition here
APM vs ALKS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ALKS has a market cap of 5.6B. Regarding current trading prices, APM is priced at $0.89, while ALKS trades at $33.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ALKS's P/E ratio is 23.43. In terms of profitability, APM's ROE is -0.06%, compared to ALKS's ROE of +0.14%. Regarding short-term risk, APM is more volatile compared to ALKS. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ALKS's competition here
APM vs SRRK Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, SRRK has a market cap of 5.5B. Regarding current trading prices, APM is priced at $0.89, while SRRK trades at $48.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas SRRK's P/E ratio is -14.62. In terms of profitability, APM's ROE is -0.06%, compared to SRRK's ROE of -1.46%. Regarding short-term risk, APM is more volatile compared to SRRK. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check SRRK's competition here
APM vs ABCM Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ABCM has a market cap of 5.5B. Regarding current trading prices, APM is priced at $0.89, while ABCM trades at $23.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ABCM's P/E ratio is 2399.00. In terms of profitability, APM's ROE is -0.06%, compared to ABCM's ROE of -0.01%. Regarding short-term risk, APM is more volatile compared to ABCM. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ABCM's competition here
APM vs ISEE Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ISEE has a market cap of 5.5B. Regarding current trading prices, APM is priced at $0.89, while ISEE trades at $39.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ISEE's P/E ratio is -22.44. In terms of profitability, APM's ROE is -0.06%, compared to ISEE's ROE of -0.39%. Regarding short-term risk, APM is more volatile compared to ISEE. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ISEE's competition here
APM vs CRSP Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CRSP has a market cap of 5.3B. Regarding current trading prices, APM is priced at $0.89, while CRSP trades at $55.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CRSP's P/E ratio is -8.59. In terms of profitability, APM's ROE is -0.06%, compared to CRSP's ROE of -0.32%. Regarding short-term risk, APM is less volatile compared to CRSP. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check CRSP's competition here
APM vs FBIOX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, FBIOX has a market cap of 5.3B. Regarding current trading prices, APM is priced at $0.89, while FBIOX trades at $25.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas FBIOX's P/E ratio is N/A. In terms of profitability, APM's ROE is -0.06%, compared to FBIOX's ROE of +0.00%. Regarding short-term risk, APM is more volatile compared to FBIOX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check FBIOX's competition here
APM vs APLS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, APLS has a market cap of 5.2B. Regarding current trading prices, APM is priced at $0.89, while APLS trades at $40.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas APLS's P/E ratio is 227.44. In terms of profitability, APM's ROE is -0.06%, compared to APLS's ROE of +0.08%. Regarding short-term risk, APM is more volatile compared to APLS. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check APLS's competition here
APM vs APGE Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, APGE has a market cap of 5.1B. Regarding current trading prices, APM is priced at $0.89, while APGE trades at $90.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas APGE's P/E ratio is -21.51. In terms of profitability, APM's ROE is -0.06%, compared to APGE's ROE of -0.37%. Regarding short-term risk, APM is more volatile compared to APGE. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check APGE's competition here
APM vs CORT Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CORT has a market cap of 4.8B. Regarding current trading prices, APM is priced at $0.89, while CORT trades at $45.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CORT's P/E ratio is 55.00. In terms of profitability, APM's ROE is -0.06%, compared to CORT's ROE of +0.15%. Regarding short-term risk, APM is less volatile compared to CORT. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check CORT's competition here
APM vs TERN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, TERN has a market cap of 4.8B. Regarding current trading prices, APM is priced at $0.89, while TERN trades at $52.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas TERN's P/E ratio is -51.32. In terms of profitability, APM's ROE is -0.06%, compared to TERN's ROE of -0.20%. Regarding short-term risk, APM is more volatile compared to TERN. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check TERN's competition here
APM vs MIRM Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, MIRM has a market cap of 4.7B. Regarding current trading prices, APM is priced at $0.89, while MIRM trades at $93.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas MIRM's P/E ratio is -198.57. In terms of profitability, APM's ROE is -0.06%, compared to MIRM's ROE of -0.09%. Regarding short-term risk, APM is more volatile compared to MIRM. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check MIRM's competition here
APM vs LEGN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, LEGN has a market cap of 4.7B. Regarding current trading prices, APM is priced at $0.89, while LEGN trades at $25.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas LEGN's P/E ratio is -15.57. In terms of profitability, APM's ROE is -0.06%, compared to LEGN's ROE of -0.29%. Regarding short-term risk, APM is less volatile compared to LEGN. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check LEGN's competition here
APM vs FOLD Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, FOLD has a market cap of 4.5B. Regarding current trading prices, APM is priced at $0.89, while FOLD trades at $14.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas FOLD's P/E ratio is -160.67. In terms of profitability, APM's ROE is -0.06%, compared to FOLD's ROE of -0.12%. Regarding short-term risk, APM is more volatile compared to FOLD. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check FOLD's competition here
APM vs LGND Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, LGND has a market cap of 4.5B. Regarding current trading prices, APM is priced at $0.89, while LGND trades at $226.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas LGND's P/E ratio is 36.98. In terms of profitability, APM's ROE is -0.06%, compared to LGND's ROE of +0.14%. Regarding short-term risk, APM is less volatile compared to LGND. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check LGND's competition here
APM vs AKRO Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, AKRO has a market cap of 4.5B. Regarding current trading prices, APM is priced at $0.89, while AKRO trades at $54.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas AKRO's P/E ratio is -14.57. In terms of profitability, APM's ROE is -0.06%, compared to AKRO's ROE of -0.31%. Regarding short-term risk, APM is more volatile compared to AKRO. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check AKRO's competition here
APM vs ALPN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ALPN has a market cap of 4.5B. Regarding current trading prices, APM is priced at $0.89, while ALPN trades at $64.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ALPN's P/E ratio is -101.52. In terms of profitability, APM's ROE is -0.06%, compared to ALPN's ROE of -0.13%. Regarding short-term risk, APM is more volatile compared to ALPN. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ALPN's competition here
APM vs XENE Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, XENE has a market cap of 4.5B. Regarding current trading prices, APM is priced at $0.89, while XENE trades at $56.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas XENE's P/E ratio is -12.94. In terms of profitability, APM's ROE is -0.06%, compared to XENE's ROE of -0.56%. Regarding short-term risk, APM is more volatile compared to XENE. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check XENE's competition here
APM vs SYRE Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, SYRE has a market cap of 4.3B. Regarding current trading prices, APM is priced at $0.89, while SYRE trades at $71.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas SYRE's P/E ratio is -35.99. In terms of profitability, APM's ROE is -0.06%, compared to SYRE's ROE of -0.29%. Regarding short-term risk, APM is less volatile compared to SYRE. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check SYRE's competition here
APM vs OPT Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, OPT has a market cap of 4.2B. Regarding current trading prices, APM is priced at $0.89, while OPT trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas OPT's P/E ratio is -1.52. In terms of profitability, APM's ROE is -0.06%, compared to OPT's ROE of +0.88%. Regarding short-term risk, APM is more volatile compared to OPT. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check OPT's competition here
APM vs MRTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, MRTX has a market cap of 4.1B. Regarding current trading prices, APM is priced at $0.89, while MRTX trades at $58.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas MRTX's P/E ratio is -4.82. In terms of profitability, APM's ROE is -0.06%, compared to MRTX's ROE of -0.62%. Regarding short-term risk, APM is more volatile compared to MRTX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check MRTX's competition here
APM vs CRNX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CRNX has a market cap of 4.1B. Regarding current trading prices, APM is priced at $0.89, while CRNX trades at $38.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CRNX's P/E ratio is -7.86. In terms of profitability, APM's ROE is -0.06%, compared to CRNX's ROE of -0.41%. Regarding short-term risk, APM is less volatile compared to CRNX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check CRNX's competition here
APM vs VKTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, VKTX has a market cap of 3.9B. Regarding current trading prices, APM is priced at $0.89, while VKTX trades at $33.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas VKTX's P/E ratio is -10.60. In terms of profitability, APM's ROE is -0.06%, compared to VKTX's ROE of -0.48%. Regarding short-term risk, APM is less volatile compared to VKTX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check VKTX's competition here
APM vs RYZB Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, RYZB has a market cap of 3.8B. Regarding current trading prices, APM is priced at $0.89, while RYZB trades at $62.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas RYZB's P/E ratio is -57.86. In terms of profitability, APM's ROE is -0.06%, compared to RYZB's ROE of +0.83%. Regarding short-term risk, APM is more volatile compared to RYZB. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check RYZB's competition here
APM vs NAMS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, NAMS has a market cap of 3.7B. Regarding current trading prices, APM is priced at $0.89, while NAMS trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas NAMS's P/E ratio is -18.88. In terms of profitability, APM's ROE is -0.06%, compared to NAMS's ROE of -0.27%. Regarding short-term risk, APM is less volatile compared to NAMS. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check NAMS's competition here
APM vs CBAY Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CBAY has a market cap of 3.7B. Regarding current trading prices, APM is priced at $0.89, while CBAY trades at $32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CBAY's P/E ratio is -32.81. In terms of profitability, APM's ROE is -0.06%, compared to CBAY's ROE of -0.64%. Regarding short-term risk, APM is more volatile compared to CBAY. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check CBAY's competition here
APM vs ACAD Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ACAD has a market cap of 3.7B. Regarding current trading prices, APM is priced at $0.89, while ACAD trades at $21.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ACAD's P/E ratio is 9.48. In terms of profitability, APM's ROE is -0.06%, compared to ACAD's ROE of +0.42%. Regarding short-term risk, APM is more volatile compared to ACAD. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check ACAD's competition here
APM vs TVTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, TVTX has a market cap of 3.6B. Regarding current trading prices, APM is priced at $0.89, while TVTX trades at $38.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas TVTX's P/E ratio is -68.04. In terms of profitability, APM's ROE is -0.06%, compared to TVTX's ROE of -0.79%. Regarding short-term risk, APM is less volatile compared to TVTX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check TVTX's competition here
APM vs SWTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, SWTX has a market cap of 3.5B. Regarding current trading prices, APM is priced at $0.89, while SWTX trades at $46.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas SWTX's P/E ratio is -13.78. In terms of profitability, APM's ROE is -0.06%, compared to SWTX's ROE of -0.36%. Regarding short-term risk, APM is more volatile compared to SWTX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check SWTX's competition here
APM vs EWTX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, EWTX has a market cap of 3.5B. Regarding current trading prices, APM is priced at $0.89, while EWTX trades at $32.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas EWTX's P/E ratio is -19.91. In terms of profitability, APM's ROE is -0.06%, compared to EWTX's ROE of -0.32%. Regarding short-term risk, APM is less volatile compared to EWTX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check EWTX's competition here
APM vs TLX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, TLX has a market cap of 3.5B. Regarding current trading prices, APM is priced at $0.89, while TLX trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas TLX's P/E ratio is -511.50. In terms of profitability, APM's ROE is -0.06%, compared to TLX's ROE of -0.02%. Regarding short-term risk, APM is more volatile compared to TLX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check TLX's competition here
APM vs DNTH Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, DNTH has a market cap of 3.5B. Regarding current trading prices, APM is priced at $0.89, while DNTH trades at $90.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas DNTH's P/E ratio is -21.47. In terms of profitability, APM's ROE is -0.06%, compared to DNTH's ROE of +0.00%. Regarding short-term risk, APM is more volatile compared to DNTH. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check DNTH's competition here
APM vs TNGX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, TNGX has a market cap of 3.2B. Regarding current trading prices, APM is priced at $0.89, while TNGX trades at $27.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas TNGX's P/E ratio is -31.92. In terms of profitability, APM's ROE is -0.06%, compared to TNGX's ROE of -0.50%. Regarding short-term risk, APM is less volatile compared to TNGX. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check TNGX's competition here
APM vs DNLI Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, DNLI has a market cap of 3.2B. Regarding current trading prices, APM is priced at $0.89, while DNLI trades at $20.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas DNLI's P/E ratio is -6.78. In terms of profitability, APM's ROE is -0.06%, compared to DNLI's ROE of -0.50%. Regarding short-term risk, APM is more volatile compared to DNLI. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check DNLI's competition here
APM vs LQDA Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, LQDA has a market cap of 3.2B. Regarding current trading prices, APM is priced at $0.89, while LQDA trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas LQDA's P/E ratio is -45.29. In terms of profitability, APM's ROE is -0.06%, compared to LQDA's ROE of -2.09%. Regarding short-term risk, APM is less volatile compared to LQDA. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check LQDA's competition here
APM vs DYN Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, DYN has a market cap of 3.2B. Regarding current trading prices, APM is priced at $0.89, while DYN trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas DYN's P/E ratio is -5.54. In terms of profitability, APM's ROE is -0.06%, compared to DYN's ROE of -0.61%. Regarding short-term risk, APM is less volatile compared to DYN. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check DYN's competition here
APM vs CPRX Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, CPRX has a market cap of 3.2B. Regarding current trading prices, APM is priced at $0.89, while CPRX trades at $25.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas CPRX's P/E ratio is 15.08. In terms of profitability, APM's ROE is -0.06%, compared to CPRX's ROE of +0.24%. Regarding short-term risk, APM is more volatile compared to CPRX. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check CPRX's competition here
APM vs KNSA Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, KNSA has a market cap of 3.1B. Regarding current trading prices, APM is priced at $0.89, while KNSA trades at $42.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas KNSA's P/E ratio is 56.60. In terms of profitability, APM's ROE is -0.06%, compared to KNSA's ROE of +0.11%. Regarding short-term risk, APM is less volatile compared to KNSA. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check KNSA's competition here
APM vs BEAM Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, BEAM has a market cap of 3.1B. Regarding current trading prices, APM is priced at $0.89, while BEAM trades at $30.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas BEAM's P/E ratio is -37.86. In terms of profitability, APM's ROE is -0.06%, compared to BEAM's ROE of -0.07%. Regarding short-term risk, APM is more volatile compared to BEAM. This indicates potentially higher risk in terms of short-term price fluctuations for APM.Check BEAM's competition here
APM vs ALMS Comparison April 2026
APM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, APM stands at 5.6M. In comparison, ALMS has a market cap of 3.1B. Regarding current trading prices, APM is priced at $0.89, while ALMS trades at $24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
APM currently has a P/E ratio of -4.68, whereas ALMS's P/E ratio is -8.74. In terms of profitability, APM's ROE is -0.06%, compared to ALMS's ROE of -0.73%. Regarding short-term risk, APM is less volatile compared to ALMS. This indicates potentially lower risk in terms of short-term price fluctuations for APM.Check ALMS's competition here